ArticleMucosal immunology2021

Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity.

Vittoria Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.